TY - JOUR ID - 47627 TI - Aldolase C Profiling in Serum after Mild Traumatic Brain Injury: A Prospective Cohort Study JO - Iranian Journal of Medical Sciences JA - IJMS LA - en SN - 0253-0716 AU - Haddadi, Kaveh AU - Moradi, Siavash AU - Asadian, Leila AU - Montazer, Seyed Hosein AU - Hosseininejad, Seyed Mohammad AU - Golikhatir, Iraj AU - Abedian Kenari, Saeid AU - Alaee, Abdulrassol AU - Bozorgi, Farzad AD - Department of Neurosurgery, School of Medicine, Orthopedic Research Center, Mazandaran University of Medical Sciences, Sari, Iran AD - Education Development Center, School of Medicine, Mazandaran University of Medical Sciences, Sari, Iran AD - Student Research Committee, Mazandaran University of Medical Sciences, Sari, Iran AD - Department of Emergency Medicine, School of Medicine, Orthopedic Research Center, Mazandaran University of Medical Sciences, Sari, Iran AD - Department of Emergency Medicine, School of Medicine, Diabetes Research Center, Mazandaran University of Medical Sciences, Sari, Iran AD - Department of Emergency Medicine, School of Medicine, Mazandaran University of Medical Sciences, Sari, Iran AD - Immunogenetics Research Center, Mazandaran University of Medical Sciences, Sari, Iran AD - Department of Radiology, School of Medicine, Mazandaran University of Medical Sciences, Sari, Iran Y1 - 2022 PY - 2022 VL - 47 IS - 1 SP - 33 EP - 39 KW - serum KW - Brain injuries KW - Traumatic KW - Biomarker DO - 10.30476/ijms.2021.87692.1831 N2 - Background: After a traumatic brain injury (TBI), in addition to clinical indices, the serum level of neurological biomarkers may provide valuable diagnostic and prognostic information. The present study aimed to investigate the aldolase C (ALDOC) profile in serum for early diagnosis of brain damage in patients with mild TBI (mTBI) presented to the Emergency Department (ED).Methods: A single-center prospective cohort study was carried out in 2018-2019 at Imam Khomeini Hospital affiliated with Mazandaran University of Medical Sciences, Sari, Iran. A total of 89 patients with mTBI were enrolled in the study. Blood samples were taken within three hours after head trauma to measure ALDOC serum levels. Brain CT scan was used as the gold standard. Statistical analysis was performed using the Kruskal Wallis, Mann-Whitney U, and Chi square tests. The receiver-operating characteristic (ROC) curve plot was used to determine the optimal cutoff point for ALDOC. The sensitivity and specificity of the determined cutoff point were calculated. P values less than 0.05 were considered statistically significant.Results: Of the 89 patients, the CT scan findings showed a positive TBI in 30 (33.7%) of the patients and in 59 (66.3%) a negative TBI. The median ALDOC serum level in the patients with positive CT scan findings (8.35 ng/mL [IQR: 1.65]) was significantly higher than those with negative CT scan findings (5.3 ng/mL [IQR: 6.9]) (p <0.001). The optimal cutoff point for ALDOC serum level was 6.95 ng/mL, and the area under the curve was 99.6% (p <0.001). The sensitivity and specificity of the determined cutoff point were 100% and 98%, respectively. Conclusion: The ALDOC serum level in patients with mTBI significantly correlates with the pathologic findings of the brain CT scan. This biomarker, with 100% sensitivity, is a suitable tool to detect brain structural abnormalities in mTBI patients. UR - https://ijms.sums.ac.ir/article_47627.html L1 - https://ijms.sums.ac.ir/article_47627_1c7768c404bd12ff670910d546aa5e9e.pdf ER -